Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neisseria meningitidis serogroup Y capsular polysaccharide conjugate antigen (MenY CPS)
- Target
- MenY CPS
- Molecular classification
- Polysaccharide, Antigen, Vaccine component
01
Overview
The Neisseria meningitidis serogroup Y capsular polysaccharide conjugate antigen is a vaccine component designed to induce immunity against infections caused by *Neisseria meningitidis* serogroup Y. This polysaccharide is conjugated to a carrier protein to enhance immunogenicity, especially in young children. It elicits a T-cell dependent immune response, leading to the production of antibodies that protect against invasive disease.
- Other names
- Serogroup Y polysaccharideN. meningitidis serogroup Y capsular polysaccharideMenY capsular polysaccharide
02
Mechanism of action
Induction of T-cell dependent immune response and antibody production against Neisseria meningitidis serogroup Y.
03
Biological functions
Immune response inductionAntibody productionBacterial opsonizationComplement activation
04
Disease associations
InfectionMeningitisInvasive meningococcal disease
05
Safety considerations
Injection site reactionsFeverAllergic reactions
06
Interacting drugs
Nimenrix®
3 more in the full profile.
07
Biomarkers
Anti-MenY capsular polysaccharide IgG antibody titers
Beyond the preview
Go deeper on Neisseria meningitidis serogroup Y capsular polysaccharide conjugate antigen (MenY CPS).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neisseria meningitidis serogroup Y capsular polysaccharide conjugate antigen (MenY CPS).